{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:02:26Z","timestamp":1784869346739,"version":"3.55.0"},"reference-count":377,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is an idiopathic, multisystem disorder marked by debilitating fatigue, post-exertional malaise, cognitive dysfunction and neuroinflammation. Its etiology remains unclear, yet emerging evidence implicates a complex interplay between immune dysregulation, metabolic impairment, mitochondrial bioenergetics, and environmental stressors such as viral infection or low-dose ionizing radiation (LDIR). To develop treatments for ME\/CFS, it is essential to identify suitable targets for therapy. In this narrative review, we discuss recent findings on the overlap of ME\/CFS with LDIR effects and examine potential mechanistic links that may arise from LDIR-induced bystander effects (RIBEs). We highlight potential candidate biomarkers that bridge these domains: mitochondrial respiratory dysfunction, altered ornithine transport via SLC25A15 (ORNT1), possible roles of CD38 in the context of immunity and NAD+ depletion, cyclin D1\u2013dependent metabolic reprogramming and modulation of gene expression, and \u03b1-synuclein as a potential neuroinflammatory damage-associated molecular pattern (DAMP). While the involvement of these biomarkers in ME\/CFS is yet to be confirmed experimentally, evidence from in vitro studies of irradiated cells, exosome profiling, and patient samples suggests that RIBEs can, in theory, produce prominent cellular ME\/CFS phenotypes through associated mechanisms, including those exhibiting oxidative stress, impaired ATP production, and immune modulation. We propose a hypothetical, exploratory model wherein LDIR initiates or contributes to adaptive metabolic shifts (including CD38 upregulation and cyclin D1 stabilization) that, coupled with persistent bystander signaling, could potentially culminate in chronic fatigue and neurocognitive symptoms in some reported ME\/CFS cases. Finally, we outline a research agenda encompassing the establishment of standardized diagnostic criteria, multi-omics profiling of patient cohorts, exosome analysis, functional mitochondrial assays, and targeted therapeutic trials focusing on possible anti-CD38 antibodies and NAD+ precursor therapy. By integrating recent findings in low-dose radiation biology with ME\/CFS pathophysiology, this review aims to promote interdisciplinary investigations that may uncover mechanistic insights and novel biomarkers for diagnosis and treatment of ME\/CFS. We further review steps in a proposed model taking us from low-dose radiation exposure to a number of possible targets.<\/jats:p>","DOI":"10.3390\/ijms27146535","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:01:28Z","timestamp":1784768488000},"page":"6535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Ionizing Radiation and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): A Review of Recent Evidence and Future Research Directions Toward the Elucidation of a Metabolic, Immunologic, and Signaling Cascade"],"prefix":"10.3390","volume":"27","author":[{"given":"Andrej","family":"Rusin","sequence":"first","affiliation":[{"name":"Department of Integrated Biomedical Engineering and Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cocchetto","sequence":"additional","affiliation":[{"name":"National CFIDS Foundation Inc., Hull, MA 02045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-3377","authenticated-orcid":false,"given":"Carmel","family":"Mothersill","sequence":"additional","affiliation":[{"name":"Department of Biology, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e003973","DOI":"10.1136\/bmjopen-2013-003973","article-title":"Case definitions for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): A systematic review","volume":"4","author":"Brurberg","year":"2014","journal-title":"BMJ Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12967-025-07506-y","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Diagnosis and management","volume":"24","author":"Fan","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","article-title":"Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Lim","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bansal, A.S. (2016). Investigating unexplained fatigue in general practice with a particular focus on CFS\/ME. BMC Fam. Pract., 17.","DOI":"10.1186\/s12875-016-0493-0"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Deumer, U.-S., Varesi, A., Floris, V., Savioli, G., Mantovani, E., L\u00f3pez-Carrasco, P., Rosati, G.M., Prasad, S., and Ricevuti, G. (2021). Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): An overview. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204786"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Geraghty, K.J., and Adeniji, C. (2019). The importance of accurate diagnosis of ME\/CFS in children and adolescents: A commentary. Front. Pediatr., 6.","DOI":"10.3389\/fped.2018.00435"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21641846.2020.1757809","article-title":"Solving the ME\/CFS criteria and name conundrum: The aftermath of IOM","volume":"8","author":"Jason","year":"2020","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/09638288.2022.2043462","article-title":"Evaluating case diagnostic criteria for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Toward an empirical case definition","volume":"45","author":"Conroy","year":"2023","journal-title":"Disabil. Rehabil."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12967-020-02455-0","article-title":"Review of case definitions for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"18","author":"Lim","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12967-025-06220-z","article-title":"mTORC1 syndrome (TorS): Unifying paradigm for PASC, ME\/CFS and PAIS","volume":"23","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Trautmann, A. (2025). Core features and inherent diversity of post-acute infection syndromes. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1509131"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/21641846.2025.2556941","article-title":"Muscle strength, muscle endurance, voluntary activation, and perception of effort in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): An overview","volume":"14","author":"Nuzzo","year":"2026","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/21641846.2017.1287546","article-title":"Identifying symptom subgroups in patients with ME\/CFS\u2013relationships to functioning and quality of life","volume":"5","author":"Wicksell","year":"2017","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_14","first-page":"10","article-title":"Subtyping patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) by course of illness","volume":"2","author":"Stoothoff","year":"2017","journal-title":"J. Biosens. Biomark. Diagn."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Murga, I., Aranburu, L., Gargiulo, P.A., Esteban, J.C.G., and Lafuente, J.-V. (2021). Clinical heterogeneity in ME\/CFS. A way to understand long-COVID19 fatigue. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.735784"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychores.2017.11.007","article-title":"Chronic fatigue syndrome (CFS\/ME) symptom-based phenotypes and 1-year treatment outcomes in two clinical cohorts of adult patients in the UK and The Netherlands","volume":"104","author":"Collin","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"ref_17","first-page":"1000190","article-title":"Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME)","volume":"5","author":"Hardcastle","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.psym.2017.04.010","article-title":"Comorbidity in chronic fatigue syndrome\/myalgic encephalomyelitis: A nationwide population-based cohort study","volume":"58","author":"Faro","year":"2017","journal-title":"Psychosomatics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12967-021-02713-9","article-title":"Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers","volume":"19","author":"Asprusten","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Maya, J. (2023). Surveying the metabolic and dysfunctional profiles of T cells and NK cells in myalgic encephalomyelitis\/chronic fatigue syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241511937"},{"key":"ref_21","first-page":"e157621","article-title":"Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Germain","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Komaroff, A.L., and Lipkin, W.I. (2023). ME\/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1187163"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Glass, K.A., Germain, A., Huang, Y.V., and Hanson, M.R. (2023). Urine metabolomics exposes anomalous recovery after maximal exertion in female ME\/CFS patients. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043685"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Baraniuk, J.N. (2025). Exertional Exhaustion (Post-Exertional Malaise, PEM) Evaluated by the Effects of Exercise on Cerebrospinal Fluid Metabolomics\u2013Lipidomics and Serine Pathway in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031282"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Van Campenhout, J., Buntinx, Y., Xiong, H.-Y., Wyns, A., Polli, A., Nijs, J., Aerts, J.L., Laeremans, T., and Hendrix, J. (2025). Unravelling the Connection Between Energy Metabolism and Immune Senescence\/Exhaustion in Patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Biomolecules, 15.","DOI":"10.3390\/biom15030357"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12967-023-04635-0","article-title":"Evaluation of viral infection as an etiology of ME\/CFS: A systematic review and meta-analysis","volume":"21","author":"Hwang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hanson, M.R. (2023). The viral origin of myalgic encephalomyelitis\/chronic fatigue syndrome. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011523"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2426564122","DOI":"10.1073\/pnas.2426564122","article-title":"Oxidative stress is a shared characteristic of ME\/CFS and Long COVID","volume":"122","author":"Shankar","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wong, T.L., and Weitzer, D.J. (2021). Long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)\u2014A systemic review and comparison of clinical presentation and symptomatology. Medicina, 57.","DOI":"10.3390\/medicina57050418"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Jason, L.A., and Katz, B.Z. (2025). Predisposing and Precipitating Factors in Epstein\u2013Barr Virus-Caused Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Microorganisms, 13.","DOI":"10.3390\/microorganisms13040702"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kerr, J. (2020). Early growth response gene upregulation in Epstein\u2013Barr Virus (EBV)-associated myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Biomolecules, 10.","DOI":"10.3390\/biom10111484"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","article-title":"Chronic viral infections in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"16","author":"Rasa","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clinthera.2023.12.011","article-title":"Joint flexibility and myalgic encephalomyelitis\/chronic fatigue syndrome after mononucleosis","volume":"46","author":"Poomkudy","year":"2024","journal-title":"Clin. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pricoco, R., Meidel, P., Hofberger, T., Zietemann, H., Mueller, Y., Wiehler, K., Michel, K., Paulick, J., Leone, A., and Haegele, M. (2024). One-year follow-up of young people with ME\/CFS following infectious mononucleosis by Epstein-Barr virus. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1266738"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2767-5122\/2021\/1.1129","article-title":"Predictors for developing severe myalgic encephalomyelitis\/chronic fatigue syndrome following infectious mononucleosis","volume":"4","author":"Jason","year":"2022","journal-title":"J. Rehabil. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e3740","DOI":"10.1093\/cid\/ciaa1886","article-title":"Risks for developing myalgic encephalomyelitis\/chronic fatigue syndrome in college students following infectious mononucleosis: A prospective cohort study","volume":"73","author":"Jason","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.7861\/clinmed.2020-0204","article-title":"Long-term sequelae following previous coronavirus epidemics","volume":"21","year":"2021","journal-title":"Clin. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Blomberg, J., Rizwan, M., B\u00f6hlin-Wiener, A., Elfaitouri, A., Julin, P., Zachrisson, O., Ros\u00e9n, A., and Gottfries, C.-G. (2019). Antibodies to human herpesviruses in myalgic encephalomyelitis\/chronic fatigue syndrome patients. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01946"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1016\/j.vaccine.2015.10.018","article-title":"Chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine","volume":"33","author":"Magnus","year":"2015","journal-title":"Vaccine"},{"key":"ref_40","first-page":"20499361211009384","article-title":"COVID-19 and post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome: A narrative review","volume":"8","author":"Poenaru","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chom.2023.01.004","article-title":"Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME\/CFS","volume":"31","author":"Guo","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"K\u00f6nig, R.S., Albrich, W.C., Kahlert, C.R., Bahr, L.S., L\u00f6ber, U., Vernazza, P., Scheibenbogen, C., and Forslund, S.K. (2022). The gut microbiome in myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS). Front. Immunol., 12, Erratum in Front Immunol.\u00a02022, 13, 878196. https:\/\/doi.org\/10.3389\/fimmu.2022.878196.","DOI":"10.3389\/fimmu.2021.628741"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mart\u00edn, F., Blanco-Su\u00e1rez, M., Zambrano, P., C\u00e1ceres, O., Almirall, M., Alegre-Mart\u00edn, J., Lobo, B., Gonz\u00e1lez-Castro, A.M., Santos, J., and Domingo, J.C. (2023). Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome: Implications for disease-related biomarker discovery. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1253121"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/21641846.2013.843255","article-title":"Beyond myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) symptom severity: Stress management skills are related to lower illness burden","volume":"1","author":"Lattie","year":"2013","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Maes, M., and Twisk, F.N.M. (2010). Chronic fatigue syndrome: Harvey and Wessely\u2019s (bio) psychosocial model versus a bio (psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-35"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17694","DOI":"10.1007\/s12144-025-08248-2","article-title":"Beyond fatigue: An intersectional analysis of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and social identities","volume":"44","author":"Sirotiak","year":"2025","journal-title":"Curr. Psychol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12967-018-1713-2","article-title":"Increased risk of chronic fatigue syndrome following burn injuries","volume":"16","author":"Tsai","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1042\/BCJ20220154","article-title":"The potential role of ischaemia\u2013reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME\/CFS: Evidence, mechanisms, and therapeutic implications","volume":"479","author":"Kell","year":"2022","journal-title":"Biochem. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e070366","DOI":"10.1136\/bmjopen-2022-070366","article-title":"Identifying, synthesising and appraising existing evidence relating to myalgic encephalomyelitis\/chronic fatigue syndrome and pregnancy: A mixed-methods systematic review","volume":"13","author":"Slack","year":"2023","journal-title":"BMJ Open"},{"key":"ref_50","first-page":"15","article-title":"A family with ME\/CFS following exposure to molds, mycotoxins and bacteria in a water-damaged home: A case report","volume":"4","author":"Thrasher","year":"2016","journal-title":"Int. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wu, T.Y., Khorramshahi, T., Taylor, L.A., Bansal, N.S., Rodriguez, B., and Rey, I.R. (2022). Prevalence of Aspergillus-derived mycotoxins (ochratoxin, aflatoxin, and gliotoxin) and their distribution in the urinalysis of ME\/CFS patients. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19042052"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2018.08.004","article-title":"Dampness and mold hypersensitivity syndrome and vaccination as risk factors for chronic fatigue syndrome","volume":"18","author":"Tuuminen","year":"2019","journal-title":"Autoimmune Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome\u2013evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_54","first-page":"429","article-title":"Autoimmunity in chronic fatigue syndrome in children","volume":"8","author":"Itoh","year":"1998","journal-title":"Jpn. J. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Blomberg, J., Gottfries, C.-G., Elfaitouri, A., Rizwan, M., and Ros\u00e9n, A. (2018). Infection elicited autoimmunity and myalgic encephalomyelitis\/chronic fatigue syndrome: An explanatory model. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00229"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lee, J.-S., Lacerda, E., Kingdon, C., Abken, E., Susannini, G., Dockrell, H.M., Nacul, L., and Cliff, J.M. (2025). Abnormal T-Cell Activation And Cytotoxic T-Cell Frequency Discriminates Symptom Severity In Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. medRxiv.","DOI":"10.1101\/2025.01.02.24319359"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"37303","DOI":"10.1038\/s41598-025-21230-z","article-title":"HLA and pathogens in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and other post-infection conditions","volume":"15","author":"Georgopoulos","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2021.03.023","article-title":"Skewing of the B cell receptor repertoire in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"95","author":"Sato","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Glassford, J.A.G. (2017). The neuroinflammatory etiopathology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00088"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Tate, W., Walker, M., Sweetman, E., Helliwell, A., Peppercorn, K., Edgar, C., Blair, A., and Chatterjee, A. (2022). Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.877772"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103484","DOI":"10.1016\/j.autrev.2023.103484","article-title":"Brain-regional characteristics and neuroinflammation in ME\/CFS patients from neuroimaging: A systematic review and meta-analysis","volume":"23","author":"Lee","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_62","first-page":"76","article-title":"Chronic fatigue syndrome in the Chernobyl accident consequences liquidators","volume":"3","author":"Loganovsky","year":"2001","journal-title":"Int. J. Radiat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J092v07n03_02","article-title":"Vegetative-vascular dystonia and osteoalgetic syndrome or Chronic Fatigue Syndrome as a characteristic after-effect of radioecological disaster: The Chernobyl accident experience","volume":"7","author":"Loganovsky","year":"2000","journal-title":"J. Chronic Fatigue Syndr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"16976","DOI":"10.1038\/srep16976","article-title":"BRAF V600E mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: A different oncogenic profile from Chernobyl","volume":"5","author":"Mitsutake","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/thy.2015.0564","article-title":"Comprehensive survey results of childhood thyroid ultrasound examinations in Fukushima in the first four years after the Fukushima Daiichi Nuclear Power Plant accident","volume":"26","author":"Suzuki","year":"2016","journal-title":"Thyroid"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/srep00507","article-title":"Thyroid doses for evacuees from the Fukushima nuclear accident","volume":"2","author":"Tokonami","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0096340211421588","article-title":"The radiological and psychological consequences of the Fukushima Daiichi accident","volume":"67","year":"2011","journal-title":"Bull. At. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/471419a","article-title":"Radiation risks unknown: Scientists struggle to calculate long-term effects of low-dose exposures in Fukushima","volume":"471","author":"Zakaib","year":"2011","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clon.2016.01.002","article-title":"Emergency responses and health consequences after the Fukushima accident; evacuation and relocation","volume":"28","author":"Hasegawa","year":"2016","journal-title":"Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10406026.2021.1911392","article-title":"Contamination and a compact: Remediless environmental harm in the Marshall Islands","volume":"34","author":"Marcoux","year":"2022","journal-title":"Environ. Claims J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/rpd\/ncr370","article-title":"Radiation exposure and disease questionnaires of early entrants after the Hiroshima bombing","volume":"149","author":"Imanaka","year":"2012","journal-title":"Radiat. Prot. Dosim."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1192\/bjp.bp.110.085472","article-title":"Persistent distress after psychological exposure to the Nagasaki atomic bomb explosion","volume":"199","author":"Kim","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00127-002-0572-5","article-title":"Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions","volume":"37","author":"Yamada","year":"2002","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_74","first-page":"394","article-title":"Radiation injuries in atomic warfare with stress on fallout","volume":"76","author":"Hunter","year":"1957","journal-title":"Can. Med. Assoc. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.envres.2017.08.029","article-title":"Low doses and non-targeted effects in environmental radiation protection; where are we now and where should we go?","volume":"159","author":"Mothersill","year":"2017","journal-title":"Environ. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2203\/dose-response.07-014.Mitchel","article-title":"Cancer and low dose responses in vivo: Implications for radiation protection","volume":"5","author":"Mitchel","year":"2007","journal-title":"Dose-Response"},{"key":"ref_77","first-page":"17","article-title":"Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?","volume":"687","author":"Little","year":"2010","journal-title":"Mutat. Res.\/Fundam. Mol. Mech. Mutagen."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1667\/RADE-25-00032.1","article-title":"Development of Low Radiation Dose Biomarkers: A Commentary on Whether Non-targeted Effects Need to Be Considered","volume":"204","author":"Mothersill","year":"2025","journal-title":"Radiat. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/HP.0000000000001808","article-title":"A review of recent low-dose research and recommendations for moving forward","volume":"126","author":"Wilson","year":"2024","journal-title":"Health Phys."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1559325820949066","DOI":"10.1177\/1559325820949066","article-title":"The LNT issue is about politics and economics, not safety","volume":"18","author":"Cuttler","year":"2020","journal-title":"Dose-Response"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/HP.0b013e3181b08a20","article-title":"Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation?","volume":"97","author":"Averbeck","year":"2009","journal-title":"Health Phys."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/HP.0000000000001074","article-title":"Towards a new concept of low dose","volume":"117","author":"Mothersill","year":"2019","journal-title":"Health Phys."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jenvrad.2013.04.002","article-title":"Implications for human and environmental health of low doses of ionising radiation","volume":"133","author":"Mothersill","year":"2014","journal-title":"J. Environ. Radioact."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0146645318756844","article-title":"Radiosensitivity and transgenerational effects in non-human species","volume":"47","author":"Oughton","year":"2018","journal-title":"Ann. ICRP"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00411-006-0054-3","article-title":"Transgenerational accumulation of radiation damage in small mammals chronically exposed to Chernobyl fallout","volume":"45","author":"Ryabokon","year":"2006","journal-title":"Radiat. Environ. Biophys."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/09553002.2018.1434323","article-title":"Intercellular communication of DNA damage and oxidative status underpin bystander effects","volume":"94","author":"Mladenov","year":"2018","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2014.01.023","article-title":"The role of oxidative DNA damage in radiation induced bystander effect","volume":"356","author":"Havaki","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1874467211104020115","article-title":"Role of DNA damage and epigenetic DNA methylation changes in radiation-induced genomic instability and bystander effects in germline in vivo","volume":"4","author":"Tamminga","year":"2011","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/09553002.2010.549533","article-title":"Reactive oxygen species-induced release of signalling factors in irradiated cells triggers membrane signalling and calcium influx in bystander cells","volume":"87","author":"Lyng","year":"2011","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09553000701797062","article-title":"Bystander signal production and response are independent processes which are cell line dependent","volume":"84","author":"Vines","year":"2008","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_91","first-page":"2769","article-title":"IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation","volume":"30","author":"Pasi","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.bjc.6604358","article-title":"Mitochondria-dependent signalling pathway are involved in the early process of radiation-induced bystander effects","volume":"98","author":"Chen","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/sj.onc.1206961","article-title":"Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect","volume":"22","author":"Azzam","year":"2003","journal-title":"Oncogene"},{"key":"ref_94","first-page":"5436","article-title":"Oxidative metabolism modulates signal transduction and micronucleus formation in bystander cells from \u03b1-particle-irradiated normal human fibroblast cultures","volume":"62","author":"Azzam","year":"2002","journal-title":"Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"503559","DOI":"10.1016\/j.mrgentox.2022.503559","article-title":"Impact of the redox environment on propagation of radiation bystander effects: The modulating effect of oxidative metabolism and oxygen partial pressure","volume":"883","author":"Gonon","year":"2022","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/09553002.2012.703365","article-title":"Investigation of the mechanisms underpinning IL-6 cytokine release in bystander responses: The roles of radiation dose, radiation quality and specific ROS\/RNS scavengers","volume":"88","author":"Mariotti","year":"2012","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_97","first-page":"8437","article-title":"Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells","volume":"63","author":"Shao","year":"2003","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jella, K.K., Moriarty, R., McClean, B., Byrne, H.J., and Lyng, F.M. (2018). Reactive oxygen species and nitric oxide signaling in bystander cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195371"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2013.12.017","article-title":"Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative status","volume":"356","author":"Klammer","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/HP.0000000000000876","article-title":"Old data\u2014New concepts: Integrating \u201cindirect effects\u201d into radiation protection","volume":"115","author":"Mothersill","year":"2018","journal-title":"Health Phys."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.cotox.2022.02.008","article-title":"Radiation hormesis and dose response: Are our current concepts meaningful or useful?","volume":"30","author":"Mothersill","year":"2022","journal-title":"Curr. Opin. Toxicol."},{"key":"ref_102","unstructured":"Belyakov, O.V., Folkard, M., Prise, K.M., Michael, B.D., and Mothersill, C. (2002, January 8\u201311). Non-targeted effects of radiation: Applications for radiation protection and contribution to LNT discussion. Proceedings of the European IRPA Congress 2002, Florence, Italy."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"BR13","DOI":"10.2481\/dsj.BR-04","article-title":"Do low doses of ionizing radiation affect the human brain?","volume":"8","author":"Loganovsky","year":"2009","journal-title":"Data Sci. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jenvrad.2018.05.018","article-title":"Low dose or low dose rate ionizing radiation-induced health effect in the human","volume":"192","author":"Tang","year":"2018","journal-title":"J. Environ. Radioact."},{"key":"ref_105","first-page":"600","article-title":"Workers on transformation of the shelter object of the Chernobyl nuclear power plant into an ecologically-safe system show qEEG abnormalities and cognitive dysfunctions: A follow-up study","volume":"17","author":"Loganovsky","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijpsycho.2010.06.282","article-title":"Psychophysiological, neuroimmune and gene expression changes in chronic fatigue syndrome after low-dose radiation exposure","volume":"77","author":"Bazyka","year":"2010","journal-title":"Int. J. Psychophysiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2007.01.029","article-title":"Bystander effects induced by serum from survivors of the Chernobyl accident","volume":"35","author":"Marozik","year":"2007","journal-title":"Exp. Hematol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Cwykiel, J., and Kwiecien, G.J. (2014). Cellular therapies in post-radiation syndrome. Plastic and Reconstructive Surgery: Experimental Models and Research Designs, Springer.","DOI":"10.1007\/978-1-4471-6335-0_75"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.prro.2017.09.002","article-title":"Factors associated with fatigue in prostate cancer (PC) patients undergoing external beam radiation therapy (EBRT)","volume":"8","author":"Chao","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1667\/RR14072.1","article-title":"Localized external beam radiation therapy (EBRT) to the pelvis induces systemic IL-1Beta and TNF-alpha production: Role of the TNF-alpha signaling in EBRT-induced fatigue","volume":"185","author":"McDonald","year":"2016","journal-title":"Radiat. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.prro.2020.05.011","article-title":"Factors associated with fatigue in patients with breast cancer undergoing external beam radiation therapy","volume":"10","author":"LaRiviere","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ijrobp.2021.11.022","article-title":"Risk factors for late persistent fatigue after chemoradiotherapy in patients with locally advanced cervical cancer: An analysis from the EMBRACE-I study","volume":"112","author":"Smet","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_113","first-page":"937","article-title":"Radiation-induced neuroinflammation and radiation somnolence syndrome","volume":"11","author":"Chavarria","year":"2012","journal-title":"CNS Neurol. Disord.-Drug Targets Former. Curr. Drug Targets-CNS Neurol. Disord."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/104345420001700107","article-title":"Radiation somnolence syndrome","volume":"17","author":"Ryan","year":"2000","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12967-025-06146-6","article-title":"The search for a blood-based biomarker for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): From biochemistry to electrophysiology","volume":"23","author":"Clarke","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12967-024-05915-z","article-title":"Machine learning and multi-omics in precision medicine for ME\/CFS","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Maksoud, R., Magawa, C., Eaton-Fitch, N., Thapaliya, K., and Marshall-Gradisnik, S. (2023). Biomarkers for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): A systematic review. BMC Med., 21.","DOI":"10.1186\/s12916-023-02893-9"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s44324-025-00079-w","article-title":"Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME\/CFS","volume":"3","author":"Che","year":"2025","journal-title":"npj Metab. Health Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/1570159X11666131120224653","article-title":"Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS)","volume":"12","author":"Morris","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"102514","DOI":"10.1016\/j.xcrm.2025.102514","article-title":"Mapping the complexity of ME\/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction","volume":"6","author":"Heng","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e183810","DOI":"10.1172\/jci.insight.183810","article-title":"Immune exhaustion in ME\/CFS and long COVID","volume":"9","author":"Rudd","year":"2024","journal-title":"JCI Insight"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI132185","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations","volume":"130","author":"Mandarano","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Davis, L., Higgs, M., Snaith, A., Lodge, T.A., Strong, J., Espejo-Oltra, J.A., Kujawski, S., Zalewski, P., Pretorius, E., and Hoerger, M. (2025). Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis\/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia. Front. Neurosci., 19.","DOI":"10.3389\/fnins.2025.1498981"},{"key":"ref_124","first-page":"208","article-title":"Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"5","author":"Booth","year":"2012","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/21641846.2019.1580855","article-title":"The role of mitochondria in ME\/CFS: A perspective","volume":"7","author":"Tomas","year":"2019","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"a040543","DOI":"10.1101\/cshperspect.a040543","article-title":"Mitochondria","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: More than just a powerhouse","volume":"16","author":"McBride","year":"2006","journal-title":"Curr. Biol."},{"key":"ref_128","first-page":"1","article-title":"Chronic fatigue syndrome and mitochondrial dysfunction","volume":"2","author":"Myhill","year":"2009","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11011-013-9435-x","article-title":"Mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways","volume":"29","author":"Morris","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Tomas, C., Elson, J.L., Strassheim, V., Newton, J.L., and Walker, M. (2020). The effect of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) severity on cellular bioenergetic function. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231136"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4049\/jimmunol.202.Supp.126.39","article-title":"Mitochondrial alterations in NK lymphocytes from ME\/CFS patients","volume":"202","author":"Silvestre","year":"2019","journal-title":"J. Immunol."},{"key":"ref_132","first-page":"14","article-title":"Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis\/chronic fatigue syndrome: A possible approach to SARS-CoV-2 \u2018long-haulers\u2019?","volume":"7","author":"Wood","year":"2020","journal-title":"Chronic Dis. Transl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e89376","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Tomas, C., Brown, A., Strassheim, V., Elson, J., Newton, J., and Manning, P. (2017). Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE, 12, Correction in PLoS ONE\u00a02018, 13, e0192817. https:\/\/doi.org\/10.1371\/journal.pone.0192817.","DOI":"10.1371\/journal.pone.0192817"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Armstrong, C.W., Mensah, F.F.K., Leandro, M.J., Reddy, V., Gooley, P.R., Berkovitz, S., and Cambridge, G. (2024). In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME\/CFS. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1178882"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Bizjak, D.A., Ohmayer, B., Buhl, J.L., Schneider, E.M., Walther, P., Calzia, E., Jerg, A., Matits, L., and Steinacker, J.M. (2024). Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and post-COVID syndrome. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031675"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e13669","DOI":"10.1002\/jcsm.13669","article-title":"Key pathophysiological role of skeletal muscle disturbance in post COVID and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Accumulated evidence","volume":"16","author":"Scheibenbogen","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Missailidis, D., Annesley, S.J., Allan, C.Y., Sanislav, O., Lidbury, B.A., Lewis, D.P., and Fisher, P.R. (2020). An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME\/CFS patients. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints201909.0043.v2"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Missailidis, D., Sanislav, O., Allan, C.Y., Smith, P.K., Annesley, S.J., and Fisher, P.R. (2021). Dysregulated provision of oxidisable substrates to the mitochondria in ME\/CFS lymphoblasts. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042046"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1111\/ejn.15828","article-title":"Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis\/chronic fatigue syndrome stimulates human microglia to release IL-1\u03b2","volume":"56","author":"Tsilioni","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"ref_141","first-page":"1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/BST20170503","article-title":"Metabolic abnormalities in chronic fatigue syndrome\/myalgic encephalomyelitis: A mini-review","volume":"46","author":"Tomas","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s11306-015-0816-5","article-title":"Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients","volume":"11","author":"Armstrong","year":"2015","journal-title":"Metabolomics"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Li, G.-H., Han, F.-F., Kalafatis, E., Kong, Q.-P., and Xiao, W. (2025). Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME\/CFS and Long COVID. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136082"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/21641846.2013.838444","article-title":"Post-exertion malaise in chronic fatigue syndrome: Symptoms and gene expression","volume":"1","author":"Meyer","year":"2013","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/15476286.2015.1100795","article-title":"Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect","volume":"12","author":"Xu","year":"2015","journal-title":"RNA Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1038\/s41598-019-45669-z","article-title":"Radiation-Induced Bystander Effect is Mediated by Mitochondrial DNA in Exosome-Like Vesicles","volume":"9","author":"Ariyoshi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1667\/RR13337.1","article-title":"Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells","volume":"181","author":"Jella","year":"2014","journal-title":"Radiat. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1667\/RADE-20-00019.1","article-title":"Radiation-Induced Bystander Effect can be Transmitted Through Exosomes Using miRNAs as Effector Molecules","volume":"194","author":"Du","year":"2020","journal-title":"Radiat. Res."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Le, M., Fernandez-Palomo, C., McNeill, F.E., Seymour, C.B., Rainbow, A.J., and Mothersill, C.E. (2017). Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: Reconciling the mechanisms mediating the bystander effect. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173685"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1667\/RR2868.1","article-title":"Possible role of exosomes containing RNA in mediating nontargeted effect of ionizing radiation","volume":"177","author":"Irons","year":"2012","journal-title":"Radiat. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbacli.2014.04.001","article-title":"Association of mitochondrial dysfunction and fatigue: A review of the literature","volume":"1","author":"Filler","year":"2014","journal-title":"BBA Clin."},{"key":"ref_153","first-page":"68","article-title":"Up-regulation of ROS by mitochondria-dependent bystander signaling contributes to genotoxicity of bystander effects","volume":"666","author":"Chen","year":"2009","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3109\/09553002.2010.486019","article-title":"Altered mitochondrial function and genome frequency post exposure to gamma-radiation and bystander factors","volume":"86","author":"Nugent","year":"2010","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/sj.bjc.6605087","article-title":"Mitochondrial dysfunction resulting from loss of cytochrome c impairs radiation-induced bystander effect","volume":"100","author":"Yang","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_156","first-page":"131","article-title":"Radiation and chemotherapy bystander effects induce early genomic instability events: Telomere shortening and bridge formation coupled with mitochondrial dysfunction","volume":"669","author":"Gorman","year":"2009","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"117365","DOI":"10.1016\/j.bcp.2025.117365","article-title":"The differential regulation of the urea cycle in tumors goes awry","volume":"242","author":"Khedr","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","article-title":"Urea cycle disorders\u2014Update","volume":"64","author":"Matsumoto","year":"2019","journal-title":"J. Hum. Genet."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40272-025-00719-0","article-title":"Current Treatment Modalities for Urea Cycle Disorders: NA Mew et al","volume":"27","year":"2025","journal-title":"Pediatr. Drugs"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"McGregor, N.R., Armstrong, C.W., Lewis, D.P., and Gooley, P.R. (2019). Post-exertional malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME\/CFS cases. Diagnostics, 9.","DOI":"10.3390\/diagnostics9030070"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1093\/hmg\/ddaa169","article-title":"Genetic risk factors of ME\/CFS: A critical review","volume":"29","author":"Dibble","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Lacerda, E.M., Mudie, K., Kingdon, C.C., Butterworth, J.D., O\u2019Boyle, S., and Nacul, L. (2018). The UK ME\/CFS biobank: A disease-specific biobank for advancing clinical research into myalgic encephalomyelitis\/chronic fatigue syndrome. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.01026"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13023-015-0242-9","article-title":"The hyperornithinemia\u2013hyperammonemia-homocitrullinuria syndrome","volume":"10","author":"Martinelli","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2007.08.003","article-title":"Hyperornithinemia\u2013hyperammonemia\u2013homocitrullinuria syndrome with stroke-like imaging presentation: Clinical, biochemical and molecular analysis","volume":"264","author":"Rashed","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1203\/00006450-198709000-00025","article-title":"Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: Low creatine excretion and effect of citrulline, arginine, or ornithine supplement","volume":"22","author":"Bachmann","year":"1987","journal-title":"Pediatr. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11011-012-9327-5","article-title":"Impairment of brain redox homeostasis caused by the major metabolites accumulating in hyperornithinemia\u2013hyperammonemia\u2013homocitrullinuria syndrome in vivo","volume":"27","author":"Viegas","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0344-0338(96)80230-5","article-title":"Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH)-Syndrome: Ultrastructural Changes of Mitochondria in Cultured Dermal Fibroblasts of Three Patients","volume":"192","author":"Haust","year":"1996","journal-title":"Pathol.-Res. Pract."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2003.10.017","article-title":"Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family","volume":"218","author":"Korman","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brainres.2010.10.112","article-title":"Dual mechanism of brain damage induced in vivo by the major metabolites accumulating in hyperornithinemia\u2013hyperammonemia\u2013homocitrullinuria syndrome","volume":"1369","author":"Viegas","year":"2011","journal-title":"Brain Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/humu.20930","article-title":"Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study","volume":"30","author":"Tessa","year":"2009","journal-title":"Hum. Mutat."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Silvera-Ruiz, S.M., Gemperle, C., Peano, N., Olivero, V., Becerra, A., H\u00e4berle, J., Gruppi, A., Larovere, L.E., and Motrich, R.D. (2022). Immune alterations in a patient with hyperornithinemia-hyperammonemia-Homocitrullinuria syndrome: A case report. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.861516"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","article-title":"Argininosuccinate synthetase from the urea cycle to the citrulline\u2013NO cycle","volume":"270","author":"Husson","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"ref_173","first-page":"8","article-title":"Argininosuccinate synthase: At the center of arginine metabolism","volume":"2","author":"Haines","year":"2010","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.c.30289","article-title":"Argininosuccinate lyase deficiency\u2014Argininosuccinic aciduria and beyond","volume":"157","author":"Erez","year":"2011","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/gim.2011.1","article-title":"Argininosuccinate lyase deficiency","volume":"14","author":"Nagamani","year":"2012","journal-title":"Genet. Med."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Yang, M., Soga, T., Pollard, P.J., and Adam, J. (2012). The emerging role of fumarate as an oncometabolite. Front. Oncol., 2.","DOI":"10.3389\/fonc.2012.00085"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.tem.2024.12.010","article-title":"Fumarate","volume":"36","author":"Schatton","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41598-020-63139-9","article-title":"Involvement of ammonia metabolism in the improvement of endurance performance by tea catechins in mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pneurobio.2010.01.012","article-title":"Ammonia metabolism, the brain and fatigue; revisiting the link","volume":"91","author":"Wilkinson","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1038\/s41598-025-91324-1","article-title":"Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis\/chronic fatigue syndroome (ME\/CFS)","volume":"15","author":"Baraniuk","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-1989-8_20","article-title":"Exercise-induced hyperammonemia: Skeletal muscle ammonia metabolism and the peripheral and central effects","volume":"368","author":"Graham","year":"1994","journal-title":"Hepatic Encephalopathy, Hyperammonemia, and Ammonia Toxicity"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12967-023-04295-0","article-title":"A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"21","author":"Taccori","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00018-022-04380-5","article-title":"Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) complex puzzle?","volume":"79","author":"Kavyani","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cca.2012.06.022","article-title":"NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome","volume":"413","author":"Armstrong","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/nbm.1512","article-title":"Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: Comparison with major depressive disorder","volume":"23","author":"Murrough","year":"2010","journal-title":"NMR Biomed."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/21641846.2017.1280114","article-title":"Elevations of ventricular lactate levels occur in both chronic fatigue syndrome and fibromyalgia","volume":"5","author":"Natelson","year":"2017","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/nbm.2772","article-title":"Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology","volume":"25","author":"Shungu","year":"2012","journal-title":"NMR Biomed."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Yamano, E., Watanabe, Y., and Kataoka, Y. (2021). Insights into metabolite diagnostic biomarkers for myalgic encephalomyelitis\/chronic fatigue syndrome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073423"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"10732748241287904","DOI":"10.1177\/10732748241287905","article-title":"Cancer therapeutic potential and prognostic value of the SLC25 mitochondrial carrier family: A review","volume":"31","author":"Gao","year":"2024","journal-title":"Cancer Control."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jcmm.14791","article-title":"Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p","volume":"24","author":"Kong","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Cocchetto, A., Seymour, C., and Mothersill, C. (2023). A Proposed New Model to Explain the Role of Low Dose Non-DNA Targeted Radiation Exposure in Chronic Fatigue and Immune Dysfunction Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076022"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Rusin, A., Seymour, C., Cocchetto, A., and Mothersill, C. (2022). Commonalities in the features of cancer and chronic fatigue syndrome (CFS): Evidence for stress-induced phenotype instability?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020691"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.tranon.2020.100882","article-title":"Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model","volume":"14","author":"Heeran","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1667\/RR0769.1","article-title":"Increased mitochondrial mass in cells with functionally compromised mitochondria after exposure to both direct gamma radiation and bystander factors","volume":"168","author":"Nugent","year":"2007","journal-title":"Radiat. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1667\/RR3600.1","article-title":"Calcium fluxes modulate the radiation-induced bystander responses in targeted glioma and fibroblast cells","volume":"166","author":"Shao","year":"2006","journal-title":"Radiat. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1667\/RR3527.1","article-title":"The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects","volume":"165","author":"Lyng","year":"2006","journal-title":"Radiat. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1158\/0008-5472.CAN-07-0188","article-title":"Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells","volume":"67","author":"Tartier","year":"2007","journal-title":"Cancer Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.rpd.a006775","article-title":"Bystander-induced apoptosis and premature differentiation in primary urothelial explants after charged particle microbeam irradiation","volume":"99","author":"Belyakov","year":"2002","journal-title":"Radiat. Prot. Dosim."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1667\/0033-7587(2002)157[0365:IOAICE]2.0.CO;2","article-title":"Initiation of apoptosis in cells exposed to medium from the progeny of irradiated cells: A possible mechanism for bystander-induced genomic instability?","volume":"157","author":"Lyng","year":"2002","journal-title":"Radiat. Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijrobp.2007.09.039","article-title":"In vivo bystander effect: Cranial X-irradiation leads to elevated DNA damage, altered cellular proliferation and apoptosis, and increased p53 levels in shielded spleen","volume":"70","author":"Koturbash","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09553000802635047","article-title":"Bystander effect induced changes in apoptosis related proteins and terminal differentiation in invitro murine bladder cultures","volume":"85","author":"Vines","year":"2009","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_202","first-page":"35","article-title":"Apoptosis is signalled early by low doses of ionising radiation in a radiation-induced bystander effect","volume":"741\u2013742","author":"Furlong","year":"2013","journal-title":"Mutat. Res.-Fundam. Mol. Mech. Mutagen."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/rpd\/ncy271","article-title":"Biophotons in Radiobiology: Inhibitors, Communicators and Reactors","volume":"183","author":"Mothersill","year":"2019","journal-title":"Radiat. Prot. Dosim."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1667\/RR13827.1","article-title":"An observed effect of ultraviolet radiation emitted from beta-irradiated HaCaT cells upon non-beta-irradiated bystander cells","volume":"183","author":"Le","year":"2015","journal-title":"Radiat. Res."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Glar\u00eda, E., and Valledor, A.F. (2020). Roles of CD38 in the Immune Response to Infection. Cells, 9.","DOI":"10.3390\/cells9010228"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40170-018-0186-3","article-title":"CD38 is methylated in prostate cancer and regulates extracellular NAD+","volume":"6","author":"Mottahedeh","year":"2018","journal-title":"Cancer Metab."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"C521","DOI":"10.1152\/ajpcell.00451.2021","article-title":"The CD38 glycohydrolase and the NAD sink: Implications for pathological conditions","volume":"322","author":"Zeidler","year":"2022","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"113395","DOI":"10.1016\/j.biopha.2022.113395","article-title":"CD38: An important regulator of T cell function","volume":"153","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.REV119.009635","article-title":"Resolving the topological enigma in Ca2+ signaling by cyclic ADP-ribose and NAADP","volume":"294","author":"Lee","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Kanayama, M., and Luo, J. (2022). CD38-Induced apoptosis and mitochondrial damage is restored by nicotinamide in prostate cancer. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.890402"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-018-0558-4","article-title":"Architecture of the TRPM2 channel and its activation mechanism by ADP-ribose and calcium","volume":"562","author":"Huang","year":"2018","journal-title":"Nature"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"a040535","DOI":"10.1101\/cshperspect.a040535","article-title":"Glycolysis","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12967-019-02155-4","article-title":"Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"17","author":"Balinas","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_214","first-page":"439","article-title":"Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis\/chronic fatigue syndrome: Inverse associations with lowered CD19+ expression and CD4+\/CD8+ ratio, but no associations with (auto) immune, leaky gut, oxidative and nitrosative stress biomarkers","volume":"36","author":"Maes","year":"2015","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Cliff, J.M., King, E.C., Lee, J.-S., Sep\u00falveda, N., Wolf, A.-S., Kingdon, C., Bowman, E., Dockrell, H.M., Nacul, L., and Lacerda, E. (2019). Cellular immune function in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00796"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Humer, B., Dik, W.A., and Versnel, M.A. (2025). Advocating the role of trained immunity in the pathogenesis of ME\/CFS: A mini review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1483764"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Piedra-Quintero, Z.L., Wilson, Z., Nava, P., and Guerau-de-Arellano, M. (2020). CD38: An immunomodulatory molecule in inflammation and autoimmunity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.597959"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"e70135","DOI":"10.1111\/acel.70135","article-title":"Chronic Cellular NAD Depletion Activates a Viral Infection-Like Interferon Response Through Mitochondrial DNA Leakage","volume":"24","author":"Chini","year":"2025","journal-title":"Aging Cell"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41574-025-01211-y","article-title":"CD38 as a driver of ageing: Metabolism","volume":"22","author":"Dutta","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Fluge, \u00d8., Rekeland, I.G., S\u00f8rland, K., Alme, K., Risa, K., Bruland, O., Tronstad, K.J., and Mella, O. (2025). Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis\/chronic fatigue syndrome\u2014A clinical pilot study. Front. Med., 12, Correction in Front. Med.\u00a02025, 12, 1677216. https:\/\/doi.org\/10.3389\/fmed.2025.1677216.","DOI":"10.3389\/fmed.2025.1607353"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14712598.2025.2492774","article-title":"Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"25","author":"Wohlrab","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/09553002.2021.1962572","article-title":"Low dose ionizing radiation and the immune response: What is the role of non-targeted effects?","volume":"97","author":"Dawood","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yu, J., Ghosh, T., and Mayassi, N. (2025). Beyond the Target: A Review of Radiation-Induced Bystander Effects in Radiobiology and Radiation Therapy. Preprints.","DOI":"10.20944\/preprints202503.1099.v1"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e1255","DOI":"10.1038\/cddis.2014.220","article-title":"Radiation induces senescence and a bystander effect through metabolic alterations","volume":"5","author":"Liao","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_227","first-page":"1740","article-title":"Involvement of energy metabolism in the production of \u2018bystander effects\u2019 by radiation","volume":"82","author":"Mothersill","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.toxlet.2014.05.026","article-title":"Bystander effects of PC12 cells treated with Pb(2)(+) depend on ROS-mitochondria-dependent apoptotic signaling via gap-junctional intercellular communication","volume":"229","author":"Guo","year":"2014","journal-title":"Toxicol. Lett."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Jaiswal, H., and Lindqvist, A. (2015). Bystander communication and cell cycle decisions after DNA damage. Front. Genet., 6.","DOI":"10.3389\/fgene.2015.00063"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"101902","DOI":"10.1016\/j.isci.2020.101902","article-title":"Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis","volume":"24","author":"Shi","year":"2021","journal-title":"Iscience"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1007\/s12035-025-05243-3","article-title":"CD38-NAD(+) Axis: New Insights into Glaucoma Therapy","volume":"62","author":"Zhang","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajpath.2013.03.001","article-title":"New roles of cyclin D1","volume":"183","author":"Pestell","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood-2003-11-3837","article-title":"Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels","volume":"104","author":"Specht","year":"2004","journal-title":"Blood"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","article-title":"Minireview: Cyclin D1: Normal and abnormal functions","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/MCB.17.7.3850","article-title":"Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27 KIP1","volume":"17","author":"Aktas","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","article-title":"Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors","volume":"66","author":"Cai","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"eadw3231","DOI":"10.1126\/scisignal.adw3231","article-title":"MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells","volume":"18","author":"Nangia","year":"2025","journal-title":"Sci. Signal."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"63","DOI":"10.30683\/1929-2279.2022.11.09","article-title":"Exploring CDKs, Ras-ERK, and PI3K-Akt in abnormal signaling and cancer","volume":"11","author":"Nandi","year":"2022","journal-title":"J. Cancer Res. Updat."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1128\/MCB.02074-05","article-title":"Cyclin D1 determines mitochondrial function invivo","volume":"26","author":"Sakamaki","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devcel.2014.03.012","article-title":"Cyclin B1\/Cdk1 coordinates mitochondrial respiration for cell-cycle G2\/M progression","volume":"29","author":"Wang","year":"2014","journal-title":"Dev. cell."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/0008-5472.CAN-10-2564","article-title":"Cyclin D1 inhibits mitochondrial activity in B cells","volume":"71","author":"Tchakarska","year":"2011","journal-title":"Cancer Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.bbagen.2013.07.030","article-title":"Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing","volume":"1830","author":"Pyo","year":"2013","journal-title":"Biochim. Biophys. Acta BBA-General. Subj."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13267","article-title":"Cyclin D1\u2013Cdk4 controls glucose metabolism independently of cell cycle progression","volume":"510","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Valenzuela, C., and Brown, N.E. (2017). Cyclin D1, Metabolism, and the Autophagy-Senescence Balance. D-Type Cyclins and Cancer, Springer.","DOI":"10.1007\/978-3-319-64451-6_5"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.smhs.2022.06.005","article-title":"Effects of PGC-1\u03b1 overexpression on the myogenic response during skeletal muscle regeneration","volume":"4","author":"Washington","year":"2022","journal-title":"Sports Med. Health Sci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mito.2013.01.006","article-title":"Regulation of mitochondrial biogenesis and PGC-1\u03b1 under cellular stress","volume":"13","author":"Wenz","year":"2013","journal-title":"Mitochondrion"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1152\/ajpendo.00755.2009","article-title":"PGC-1\u03b1 regulation by exercise training and its influences on muscle function and insulin sensitivity","volume":"299","author":"Lira","year":"2010","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/apnm-2020-0005","article-title":"PGC-1\u03b1-mediated regulation of mitochondrial function and physiological implications","volume":"45","author":"Halling","year":"2020","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"e1515","DOI":"10.1038\/cddis.2014.458","article-title":"PGC-1\u03b1 buffers ROS-mediated removal of mitochondria during myogenesis","volume":"5","author":"Baldelli","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2004.09.016","article-title":"PGC-1\u03b1: Turbocharging mitochondria","volume":"119","author":"Houten","year":"2004","journal-title":"Cell"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-017-0628-x","article-title":"Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): A review of recent findings","volume":"19","author":"Gerwyn","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Cheema, A.K., Tehrani, L., Patel, S., Rozenfeld, I., Renesca, V., Fornos, A., Kempuraj, D., and Klimas, N.G. (2025). Redefining Mitochondrial Therapy for ME\/CFS: The Case for MOTS-c. Preprints, 2025070058.","DOI":"10.20944\/preprints202507.0058.v1"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.50.6.743","article-title":"Chronic fatigue and myalgia syndrome: Mitochondrial and glycolytic studies in skeletal muscle","volume":"50","author":"Byrne","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/(SICI)1097-4598(199605)19:5<621::AID-MUS10>3.0.CO;2-Q","article-title":"Reduced oxidative muscle metabolism in chronic fatigue syndrome","volume":"19","author":"McCully","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0960-8966(98)00021-2","article-title":"Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle","volume":"8","author":"Lane","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/03009742.2019.1602164","article-title":"Interleukin-6 and tumour necrosis factor-\u03b1 cooperatively promote cell cycle regulators and proliferate rheumatoid arthritis fibroblast-like synovial cells","volume":"48","author":"Kaneshiro","year":"2019","journal-title":"Scand. J. Rheumatol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4161\/cc.25746","article-title":"The role of cyclin D1 in response to long-term exposure to ionizing radiation","volume":"12","author":"Shimura","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/onc.2008.265","article-title":"Cyclin D1 in low-dose radiation-induced adaptive resistance","volume":"27","author":"Ahmed","year":"2008","journal-title":"Oncogene"},{"key":"ref_260","unstructured":"Hall, E.J., and Giaccia, A.J. (2006). Radiobiology for the Radiologist, Lippincott Williams & Wilkins."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1667\/0033-7587(2002)157[0526:RBRILD]2.0.CO;2","article-title":"Relationship between radiation-induced low-dose hypersensitivity and the bystander effect","volume":"157","author":"Mothersill","year":"2002","journal-title":"Radiat. Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1667\/0033-7587(2000)153[0508:RCOBAT]2.0.CO;2","article-title":"Relative contribution of bystander and targeted cell killing to the low-dose region of the radiation dose\u2013response curve","volume":"153","author":"Seymour","year":"2000","journal-title":"Radiat. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/HP.0b013e3182080f0c","article-title":"Radiation-Induced Non-Targeted Effects of Low Doses\u2014What, Why and How?","volume":"100","author":"Mothersill","year":"2011","journal-title":"Health Phys."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2203\/dose-response.09-054.Zhao","article-title":"Modeling dose-response at low dose: A systems biology approach for ionization radiation","volume":"8","author":"Zhao","year":"2010","journal-title":"Dose-Response"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrc2677","article-title":"Assessing cancer risks of low-dose radiation","volume":"9","author":"Mullenders","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jjco\/hys078","article-title":"Low-dose radiation exposure and carcinogenesis","volume":"42","author":"Suzuki","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1667\/RR2296.1","article-title":"The role of mitochondria in the radiation-induced bystander effect in human lymphoblastoid cells","volume":"175","author":"Rajendran","year":"2010","journal-title":"Radiat. Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1038\/s41598-018-31270-3","article-title":"Oxidative stress is a convincing contributor to idiopathic chronic fatigue","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/09553000410001692726","article-title":"Chronic oxidative stress and radiation-induced late normal tissue injury: A review","volume":"80","author":"Robbins","year":"2004","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.freeradbiomed.2005.04.020","article-title":"Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms","volume":"39","author":"Kennedy","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1517\/14728222.2013.818657","article-title":"The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: Peripheral and central mechanisms as therapeutic targets?","volume":"17","author":"Meeus","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/OTT.S136076","article-title":"Bystander signaling via oxidative metabolism","volume":"10","author":"Sawal","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and \u03b1-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","article-title":"Definition of a molecular pathway mediating \u03b1-synuclein neurotoxicity","volume":"35","author":"Sharma","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_276","first-page":"E4274","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Sharma","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00702-019-02106-9","article-title":"The catecholaldehyde hypothesis: Where MAO fits in","volume":"127","author":"Goldstein","year":"2020","journal-title":"J. Neural Transm."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1021\/acschemneuro.0c00628","article-title":"Sirt1\/FoxO1-associated MAO-A upregulation promotes depressive-like behavior in transgenic mice expressing human A53T \u03b1-synuclein","volume":"11","author":"Li","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neurol.2020.07.016","article-title":"Pathophysiology of Parkinson\u2019s disease: Mitochondria, alpha-synuclein and much more\u2026","volume":"177","author":"Rouaud","year":"2021","journal-title":"Rev. Neurol."},{"key":"ref_280","first-page":"3668","article-title":"Mechanism of alpha-synuclein in mitochondrial damage induced by Parkinson\u2019s disease","volume":"29","author":"Wang","year":"2025","journal-title":"Chin. J. Tissue Eng. Res."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12017-017-8448-8","article-title":"Individual amino acid supplementation can improve energy metabolism and decrease ROS production in neuronal cells overexpressing alpha-synuclein","volume":"19","author":"Delic","year":"2017","journal-title":"Neuromolecular Med."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"e98878","DOI":"10.15252\/embj.201798878","article-title":"\u03b1-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson\u2019s disease","volume":"37","author":"Kang","year":"2018","journal-title":"EMBO J."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1038\/s41380-021-01284-x","article-title":"Mitochondrial dysfunction triggers the pathogenesis of Parkinson\u2019s disease in neuronal C\/EBP\u03b2 transgenic mice","volume":"26","author":"Ahn","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Vicario, M., Cieri, D., Brini, M., and Cal\u00ec, T. (2018). The close encounter between alpha-synuclein and mitochondria. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00388"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13311-013-0182-9","article-title":"A-Synuclein and mitochondria: Partners in crime?","volume":"10","author":"Nakamura","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","article-title":"Mitochondrial association of alpha-synuclein causes oxidative stress","volume":"65","author":"Parihar","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"A-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Liu","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"A-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/hmg\/ddaa183","article-title":"The mechanistic role of alpha-synuclein in the nucleus: Impaired nuclear function caused by familial Parkinson\u2019s disease SNCA mutations","volume":"29","author":"Chen","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Weston, L.J., Bowman, A.M., Osterberg, V.R., Meshul, C.K., Woltjer, R.L., and Unni, V.K. (2022). Aggregated alpha-synuclein inclusions within the nucleus predict impending neuronal cell death in a mouse model of Parkinsonism. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315294"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jim-2016-000390","article-title":"CNS findings in chronic fatigue syndrome and a neuropathological case report","volume":"65","author":"Ferrero","year":"2017","journal-title":"J. Investig. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_294","first-page":"1","article-title":"Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment","volume":"651","author":"Fuentes","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40478-024-01915-8","article-title":"BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson\u2019s disease","volume":"12","author":"Jishi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"2324709615607908","DOI":"10.1177\/2324709615607908","article-title":"Mitochondrial myopathy in follow-up of a patient with chronic fatigue syndrome","volume":"3","year":"2015","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12967-020-02452-3","article-title":"A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis\/chronic fatigue syndrome\/systemic exertion intolerance disease","volume":"18","author":"Holden","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"886","DOI":"10.5114\/aoms.2012.31620","article-title":"Lipid and protein oxidation in female patients with chronic fatigue syndrome","volume":"8","author":"Tomic","year":"2012","journal-title":"Arch. Med. Sci. AMS"},{"key":"ref_299","first-page":"SC11","article-title":"Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"17","author":"Maes","year":"2011","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology","volume":"133","author":"Dzamko","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2018.04.008","article-title":"Nurr1: A vital participant in the TLR4-NF-\u03baB signal pathway stimulated by \u03b1-synuclein in BV-2 cells","volume":"144","author":"Shao","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1479-5876-10-191","article-title":"Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue","volume":"10","author":"Broderick","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3988\/jcn.2016.12.2.172","article-title":"Parkinson\u2019s disease with fatigue: Clinical characteristics and potential mechanisms relevant to \u03b1-synuclein oligomer","volume":"12","author":"Zuo","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"578222","DOI":"10.1016\/j.jneuroim.2023.578222","article-title":"Plasma TNF-\u03b1 and phosphorylated \u03b1-syn are associated with fatigue in patients with Parkinson\u2019s disease","volume":"385","author":"Wang","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbi.2012.09.009","article-title":"Upregulation of \u03b1-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways","volume":"27","author":"Saligan","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41531-025-01136-3","article-title":"Evaluating Parkinson\u2019s disease biomarkers in substantia nigra following sublethal \u03b3-radiation exposure in a large animal model","volume":"11","author":"Murphy","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Sharma, N.K., Sharma, R., Mathur, D., Sharad, S., Minhas, G., Bhatia, K., Anand, A., and Ghosh, S.P. (2018). Role of ionizing radiation in neurodegenerative diseases. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00134"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pathophys.2019.02.004","article-title":"Mobile phone electromagnetic radiation affects Amyloid Precursor Protein and \u03b1-synuclein metabolism in SH-SY5Y cells","volume":"26","author":"Stefi","year":"2019","journal-title":"Pathophysiology"},{"key":"ref_311","first-page":"185","article-title":"Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: From clinical-consensus to evidence-based case definitions","volume":"34","author":"Morris","year":"2013","journal-title":"Neuroendocrinol. Lett."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21641846.2018.1396021","article-title":"Using a participatory approach to develop and implement the UK ME\/CFS Biobank","volume":"6","author":"Lacerda","year":"2018","journal-title":"Fatigue Biomed. Health Behav."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12967-022-03815-8","article-title":"Genetic risk factors for ME\/CFS identified using combinatorial analysis","volume":"20","author":"Das","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s43856-024-00669-7","article-title":"Discriminating myalgic encephalomyelitis\/chronic fatigue syndrome and comorbid conditions using metabolomics in UK Biobank","volume":"4","author":"Huang","year":"2024","journal-title":"Commun. Med."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5334\/ojb.28","article-title":"The UK ME\/CFS biobank for biomedical research on myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and multiple sclerosis","volume":"4","author":"Lacerda","year":"2017","journal-title":"Open J. Bioresour."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbi.2022.03.010","article-title":"Genetic association study in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) identifies several potential risk loci","volume":"102","author":"Hajdarevic","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3310\/nihropenres.13956.1","article-title":"Defining a High-Quality Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome cohort in UK Biobank","volume":"5","author":"Samms","year":"2025","journal-title":"NIHR Open Res."},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"Caines, J.K., Barnes, D.A., and Berry, M.D. (2022). The use of seahorse XF assays to interrogate real-time energy metabolism in cancer cell lines. Cancer Cell Biology: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-0716-2376-3_17"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"e56380","DOI":"10.15252\/embr.202256380","article-title":"Calculation of ATP production rates using the Seahorse XF Analyzer","volume":"24","author":"Desousa","year":"2023","journal-title":"EMBO Rep."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10439-007-9265-2","article-title":"Mitochondrial inner membrane electrophysiology assessed by rhodamine-123 transport and fluorescence","volume":"35","author":"Huang","year":"2007","journal-title":"Ann. Biomed. Eng."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"e3128","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-Protoc."},{"key":"ref_323","first-page":"361","article-title":"MitoSOX-based flow cytometry for detecting mitochondrial ROS","volume":"2","author":"Kauffman","year":"2016","journal-title":"React. Oxyg. Species"},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Eruslanov, E., and Kusmartsev, S. (2009). Identification of ROS using oxidized DCFDA and flow-cytometry. Advanced Protocols in Oxidative Stress II, Springer.","DOI":"10.1007\/978-1-60761-411-1_4"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vascn.2018.03.007","article-title":"Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2\u2032, 7\u2032\u2013dichlorofluorescin diacetate (DCFDA) assay","volume":"94","author":"Figueroa","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0143-4160(90)90060-8","article-title":"Assessment of Fura-2 for measurements of cytosolic free calcium","volume":"11","author":"Roe","year":"1990","journal-title":"Cell Calcium"},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Barreto-Chang, O.L., and Dolmetsch, R.E. (2009). Calcium imaging of cortical neurons using Fura-2 AM. J. Vis. Exp. JoVE, 1067.","DOI":"10.3791\/1067"},{"key":"ref_328","first-page":"13","article-title":"Variability of the adaptive response to ionizing radiations in humans","volume":"211","author":"Bosi","year":"1989","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09553002.2014.937510","article-title":"Molecular mechanisms of low dose ionizing radiation-induced hormesis, adaptive responses, radioresistance, bystander effects, and genomic instability","volume":"91","author":"Tang","year":"2015","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2203\/dose-response.06-111.Mothersill","article-title":"Radiation-induced bystander effects: Evidence for an adaptive response to low dose exposures?","volume":"4","author":"Mothersill","year":"2006","journal-title":"Dose-Response"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2013.09.015","article-title":"Contribution of the immune system to bystander and non-targeted effects of ionizing radiation","volume":"356","author":"Rodel","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_332","first-page":"229","article-title":"Effect of radiation-induced bystander chemosignals of mice on the humoral immune response in spleen and lymph nodes of intact recipients","volume":"52","author":"Kharlamov","year":"2011","journal-title":"Radiatsionnaia Biol. Radioecol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/milmed\/167.suppl_1.66","article-title":"NF-\u03baB, cytokines, proteasomes, and low-dose radiation exposure","volume":"167","author":"Pajonk","year":"2002","journal-title":"Mil. Med."},{"key":"ref_334","unstructured":"Hallahan, D.E., Haimovitz-Friedman, A., Kufe, D.W., Fuks, Z., and Weichselbaum, R.R. (1993). The role of cytokines in radiation oncology. Important Adv. Oncol., 71\u201380."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/09553000903020016","article-title":"Experimental and theoretical analysis of cytokine release for the study of radiation-induced bystander effect","volume":"85","author":"Facoetti","year":"2009","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_336","doi-asserted-by":"crossref","unstructured":"Milivojevic, M., Che, X., Bateman, L., Cheng, A., Garcia, B.A., Hornig, M., Huber, M., Klimas, N.G., Lee, B., and Lee, H. (2020). Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME\/CFS. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236148"},{"key":"ref_337","doi-asserted-by":"crossref","unstructured":"Fluge, \u00d8., and Mella, O. (2009). Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: A preliminary case series. BMC Neurol., 9.","DOI":"10.1186\/1471-2377-9-28"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"Bradley","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12749","article-title":"Extended B cell phenotype in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: A cross-sectional study","volume":"184","author":"Mensah","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_340","first-page":"35","article-title":"Characterisation of B cell subsets and receptors in chronic fatigue syndrome patients","volume":"16","author":"Ramos","year":"2015","journal-title":"J. Clin. Cell Immunol."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jns.2017.08.2533","article-title":"Dysregulation of T and B cells in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"381","author":"Ono","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"e20220201","DOI":"10.1084\/jem.20220201","article-title":"Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells","volume":"219","author":"Camponeschi","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1399-0039.1997.tb02703.x","article-title":"Role of the human CD38 molecule in B cell activation and proliferation","volume":"49","author":"Funaro","year":"1997","journal-title":"Tissue Antigens"},{"key":"ref_344","first-page":"146","article-title":"CD38 in T-and B-cell functions","volume":"75","author":"Deterre","year":"2000","journal-title":"Chem. Immunol."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/jcp.30760","article-title":"Effect of CD38 on B-cell function and its role in the diagnosis and treatment of B-cell-related diseases","volume":"237","author":"Zeng","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mutage\/11.6.593","article-title":"Anti-CD38 prevents the development of the adaptive response induced by X-rays in human lymphocytes","volume":"11","author":"Kruszewski","year":"1996","journal-title":"Mutagenesis"},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"72","DOI":"10.7150\/jca.59730","article-title":"Integrative analysis identified CD38 as a key node that correlates highly with immunophenotype, chemoradiotherapy resistance, and prognosis of head and neck cancer","volume":"14","author":"He","year":"2023","journal-title":"J. Cancer"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1186\/s12967-024-05768-6","article-title":"CD38 as theranostic target in oncology","volume":"22","author":"Bocuzzi","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1667\/RR3158.2","article-title":"The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in murine bone marrow","volume":"179","author":"Lorimore","year":"2013","journal-title":"Radiat. Res."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.envres.2018.01.027","article-title":"Modulation of oxidative phosphorylation (OXPHOS) by radiation- induced biophotons","volume":"163","author":"Le","year":"2018","journal-title":"Environ. Res."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"1680905","DOI":"10.1155\/2016\/1680905","article-title":"Glia and TRPM2 channels in plasticity of central nervous system and Alzheimer\u2019s diseases","volume":"2016","author":"Wang","year":"2016","journal-title":"Neural Plast."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.conb.2004.05.003","article-title":"TRP ion channels in the nervous system","volume":"14","author":"Moran","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_354","doi-asserted-by":"crossref","unstructured":"Lee, K., Jo, Y.Y., Chung, G., Jung, J.H., Kim, Y.H., and Park, C.-K. (2021). Functional importance of transient receptor potential (TRP) channels in neurological disorders. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.611773"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/aps.2018.31","article-title":"TRPM2: A candidate therapeutic target for treating neurological diseases","volume":"39","author":"Belrose","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11064-010-0347-4","article-title":"TRPM2 cation channels, oxidative stress and neurological diseases: Where are we now?","volume":"36","year":"2011","journal-title":"Neurochem. Res."},{"key":"ref_357","doi-asserted-by":"crossref","unstructured":"Malko, P., Syed Mortadza, S.A., McWilliam, J., and Jiang, L.-H. (2019). TRPM2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00239"},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/15384101.2016.1170271","article-title":"Mitochondrial reactive oxygen species-mediated genomic instability in low-dose irradiated human cells through nuclear retention of cyclin D1","volume":"15","author":"Shimura","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1073\/pnas.1018941108","article-title":"A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma","volume":"108","author":"Beltran","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1523\/JNEUROSCI.21-14-05017.2001","article-title":"Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage","volume":"21","author":"Morris","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_361","first-page":"26","article-title":"Bufalin induces G0\/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells","volume":"732","author":"Huang","year":"2012","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1093\/emboj\/17.24.7209","article-title":"A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis","volume":"17","author":"Berns","year":"1998","journal-title":"EMBO J."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1093\/clinids\/18.Supplement_1.S157","article-title":"Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome","volume":"18","author":"Conley","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1038\/tp.2015.208","article-title":"Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"6","author":"Schlauch","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0269881105053293","article-title":"Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome","volume":"19","author":"Badawy","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.2001.tb05824.x","article-title":"Cytokines and chronic fatigue syndrome","volume":"933","author":"Patarca","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bbi.2010.04.012","article-title":"A formal analysis of cytokine networks in chronic fatigue syndrome","volume":"24","author":"Broderick","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/09553002.2017.1398436","article-title":"History of bystander effects research 1905-present; what is in a name?","volume":"94","author":"Mothersill","year":"2018","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","article-title":"P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest","volume":"76","author":"Kaufmann","year":"1994","journal-title":"Cell"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1073\/pnas.0603363103","article-title":"Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_371","doi-asserted-by":"crossref","unstructured":"Scheibenbogen, C., Bellmann-Strobl, J.T., Heindrich, C., Wittke, K., Stein, E., Franke, C., Pr\u00fcss, H., Pre\u00dfler, H., Machule, M.-L., and Audebert, H. (2023). Fighting Post-COVID and ME\/CFS\u2013development of curative therapies. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1194754"},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/M16-2391","article-title":"Cytokine inhibition in patients with chronic fatigue syndrome: A randomized trial","volume":"166","author":"Roerink","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12967-019-1948-6","article-title":"The clinical value of cytokines in chronic fatigue syndrome","volume":"17","author":"Yang","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1073\/pnas.1610253113","article-title":"Network pharmacology of JAK inhibitors","volume":"113","author":"Moodley","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1186\/s12967-025-07213-8","article-title":"Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME\/CFS patients via improvement of autophagy: A pilot study","volume":"23","author":"Ruan","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"1008116","DOI":"10.37349\/eds.2025.1008116","article-title":"Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)","volume":"3","author":"Aliashrafzadeh","year":"2025","journal-title":"Explor. Drug Sci."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.2147\/JIR.S414739","article-title":"Potential mechanism of fatigue induction and its management by JAK inhibitors in inflammatory rheumatic diseases","volume":"16","author":"Massalska","year":"2023","journal-title":"J. Inflamm. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:28:27Z","timestamp":1784867307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":377,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146535"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146535","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}